Autocrine and paracrine function of angiotensin 1-7 in tissue repair during hypertension

American Journal of Hypertension

Volumn 27, Issue 6, 2014, Pages 775-782

  Meng, Weixin ^a   Zhao, Wenyuan ^b   Zhao, Tieqiang ^b   Liu, Chang ^a   Chen, Yuanjian ^b   Liu, Hongyu ^a   Sun, Yao ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

angiotensin 1 7; blood pressure; heart; hypertension; kidney; Mas receptor blockade; repair

Indexed keywords

ALDOSTERONE; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; CASPASE 3; CHLORDANE; COLLAGEN; INTERCELLULAR ADHESION MOLECULE 1; MAS RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN; PROTEIN BAX; PROTEIN BCL 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; 7-ALA-ANGIOTENSIN (1-7); ANGIOTENSIN I; ANGIOTENSIN I (1-7); DIPEPTIDYL CARBOXYPEPTIDASE; G PROTEIN COUPLED RECEPTOR; ONCOPROTEIN; PEPTIDE FRAGMENT; PROTO-ONCOGENE PROTEINS C-MAS-1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; BLOOD PRESSURE; CARDITIS; CONTROLLED STUDY; DISEASE EXACERBATION; FIBROSING ALVEOLITIS; HEART FUNCTION; HEART INJURY; HEART VENTRICLE FUNCTION; HEART WEIGHT; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MORPHOLOGY; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE REPAIR; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; FIBROSIS; HEART MUSCLE; HEART VENTRICLE REMODELING; KIDNEY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ALDOSTERONE; ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; APOPTOSIS; AUTOCRINE COMMUNICATION; DISEASE MODELS, ANIMAL; FIBROSIS; HYPERTENSION; KIDNEY; MALE; MYOCARDIUM; PARACRINE COMMUNICATION; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; PROTO-ONCOGENE PROTEINS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; VENTRICULAR REMODELING;

EID: 84900003708     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpt270     Document Type: Article

References (40)

1. Zhuo JL, Li XC. New insights and perspectives on intrarenal renin-angiotensin system: focus on intracrine/intracellular angiotensin II. Peptides 2011; 32:1551-1565.
2. Dzau V. The cardiovascular continuum and renin-angiotensin-aldosterone system blockade, J Hypertens Suppl 2005; 23:S9-S17.
3. Tikellis C, Johnston CI, Forbes JM, Burns WC, Burrell LM, Risvanis J, Cooper ME. Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension 2003; 41:392-397.
4. Burrell LM, Johnston CI, Tikellis C, Cooper ME. ACE2, a new regulator of the renin-angiotensin system. Trends EndocrinolMetab 2004; 15:166-169.
5. Mercure C, Yogi A, Callera GE, Aranha AB, Bader M, Ferreira AJ, Santos RA, Walther T, Touyz RM, Reudelhuber TL. Angiotensin(l-7) blunts hypertensive cardiac remodeling by a direct effect on the heart. Q'rc fies 2008; 103:1319-1326.
6. Yamamoto K, Ohishi M, Katsuya T, Ito N, Ikushima M, Kaibe M, Tatara Y, Shiota A, Sugano S, Takeda S, Rakugi H, Ogihara T. Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II. Hypertension 2006;47:718-726.
7. Dilauro M, Burns KD. Angiotensin-(l-7) and its effects in the kidney. Sei World J 2009; 9:522-535.
8. Gavras I, Gavras H. Angiotensin II as a cardiovascular risk factor, J Hum Hypertens 2002; 16:S2-S6.
9. Taddei S, Virdis A, Abdel-Haq B, Giovannetti R, Duranti P, Arena AM, Favilla S, Salvetti A. Indirect evidence for vascular uptake of circulating renin in hypertensive patients. Hypertension 1993; 21:852-860.
10. Weber KT, Sun Y Campbell SE, Slight SH, Ganjam VK, Griffing GT, Swinfard RW, Diaz-Arias AA. Chronic mineralocorticoid excess and cardiovascular remodeling. Steroids 1995; 60:125-132.
11. Sun Y Ramires FJ, Weber KT Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion. Cardiovasc Res 1997; 35:138-147.
12. Jennings BL, Anderson LJ, Estes AM, Yaghini FA, Fang XR, Porter J, Gonzalez FJ, Campbell WB, Malik KU. Cytochrome P450 1B1 contributes to renal dysfunction and damage caused by angiotensin II in mice. Hypertension 2012; 59:348-354.
13. Sun Y Zhang J, Zhang JQ, Ramires FJ. Local angiotensin II and transforming growth factor-betal in renal fibrosis of rats. Hypertension 2000;35:1078-1084.
14. Sun Y Weber KT Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart. IMol Cell Cardiol 1996; 28:851-858.
15. Tsotetsi OJ, Woodiwiss AJ, Netjhardt M, Qubu D, Brooksbank R Norton GR. Attenuation of cardiac failure, dilatation, damage, and detrimental interstitial remodeling without regression of hypertrophy in hypertensive rats. Hypertension 2001; 38:846-851.
16. Doyle AE. Role of angiotensin-converting enzyme inhibitors in preventing or reducing end-organ damage in hypertension, J Cardiovasc Pharmacol 1992; 19: S21-S27.
17. Grobe JL, Mecca AP, Lingis M, Shenoy V, Bolton TA, Machado JM, Speth RC, Raizada MK, Katovich MJ. Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(l-7). Am J Physiol Heart Circ Physiol 2007; 292:H736-H742.
18. Zhao W, Zhao T, Chen Y Sun Y Angiotensin 1-7 Promotes cardiac angiogenesis following infarction. Curr Vase Pharmacol 2013.
19. Sun Y Ratajska A, Weber KT Inhibition of angiotensin-converting enzyme and attenuation of myocardial fibrosis by lisinopril in rats receiving angiotensin II. J Lab Clin Med 1995; 126:95-101.
20. Zhao W, Zhao T Huang V, Chen Y Ahokas RA, Sun Y Platelet-derived growth factor involvement in myocardial remodeling following infarction. J Mol Cell Cardiol 2011; 51:830-838.
21. Lopez-Andres N, Rousseau A, Akhtar R, Calvier L, Inigo C, Labat C, Zhao X, Cruickshank K, Diez J, Zannad F, Lacolley P, Rossignol P. Cardiotrophin 1 is involved in cardiac, vascular, and renal fibrosis and dysfunction. Hypertension 2012; 60:563-573.
22. Tikellis C, Thomas MC Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int } Pept 2012; 2012:256294.
23. Coulter AB, Goddard MJ, Allen JC, Clark KL. ACE2 gene expression is up-regulated in the human failing heart. BMC Med 2004; 2:19.
24. Tan Z, Wu J, Ma H. Regulation of angiotensin-converting enzyme 2 and Mas receptor by Ang-( 1-7) in heart and kidney of spontaneously hypertensive rats, J Renin Angiotensin Aldosterone Syst 2011; 12:413-419.
25. Ye M, Wysocki J, Naaz P, Salabat MR, LaPointe MS, Batlle D. Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination? Hypertension 2004; 43:1120-1125.
26. Danilczyk U, Penninger JM. Angiotensin-converting enzyme II in the heart and the kidney. Circ Res 2006; 98:463-471.
27. Falkenhahn M, Franke F, Bohle RM, Zhu YC, Stauss HM, Bachmann S, Danilov S, Unger T. Cellular distribution of angiotensin-converting enzyme after myocardial infarction. Hypertension 1995; 25:219-226.
28. Passier RC, Smits JF, Verluyten MJ, Studer R, Drexler H, Daemen MJ. Activation of angiotensin-converting enzyme expression in infarct zone following myocardial infarction. Am J Physiol 1995; 269:H1268-H1276.
29. Simoes e Silva AC, Silveira KD, Ferreira AJ, Teixeira MM. ACE2, angio-tensin-(l-7) and Mas receptor axis in inflammation and fibrosis. Br J Pharmacol 2013; 169:477-492.
30. Sukumaran V, Veeraveedu PT, Gurusamy N, Yamaguchi K, Lakshmanan AP, Ma M, Suzuki K, Kodama M, Watanabe K. Cardioprotective effects of telmisartan against heart failure in rats induced by experimental autoimmune myocarditis through the modulation of angiotensin-converting enzyme-2/angiotensin 1-7/mas receptor axis. Int I Biol Sei 2011; 7:1077-1092.
31. Lo J, Patel VB, Wang Z, Levasseur J, Kaufman S, Penninger JM, Oudit GY Angiotensin-converting enzyme 2 antagonizes angiotensin II-induced pressor response and NADPH oxidase activation in Wistar-Kyoto rats and spontaneously hypertensive rats. Exp Physiol 2013; 98:109-122.
32. Neves MF, Amiri F, Virdis A, Diep QN, Schiffrin EL, Hypertension CMRGo. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy. Can I Physiol Pharmacol 2005;83:999-1006.
33. Bouzeghrane F, Mercure C, Reudelhuber TL, Thibault G. Alpha8betal integrin is upregulated in myofibroblasts of fibrotic and scarring myocardium. J Mol cell Cardiol 2004; 36:343-353.
34. Lee AA, Dillmann WH, McCulloch AD, Villarreal FJ. Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts. J Mol Cell Cardiol 1995; 27:2347-2357.
35. Iwata M, Cowling RT, Gurantz D, Moore C, Zhang S, Yuan JX, Greenberg BH. Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects. Am J Physiol Heart Circ Physiol 2005; 289:H2356-H2363.
36. Zeng W, Chen W, Leng X, He JG, Ma H. Chronic angiotensin-(l-7) administration improves vascular remodeling after angioplasty through the regulation of the TGF-beta/Smad signaling pathway in rabbits. Biochem Biophys Res Commun 2009; 389:138-144.
37. Schroder D, Heger J, Piper HM, Euler G. Angiotensin II stimulates apoptosis via TGF-betal signaling in ventricular cardiomyocytes of rat. J Mol Med (Berl) 2006; 84:975-983.
38. McMurray J, Davie AP. Angiotensin-(l-7) attenuates the development of heart failure after myocardial infarction in rats. Circulation 2002; 106:el47; author reply el47.
39. Marques FD, Ferreira AJ, Sinisterra RD, Jacoby BA, Sousa FB, Caliari MV, Silva GA, Melo MB, Nadu AP, Souza LE, Irigoyen MC, Almeida AP, Santos RA. An oral formulation of angiotensin-(l-7) produces cardioprotective effects in infarcted and isoproterenol-treated rats. Hypertension 2011; 57:477-483.
40. Der Sarkissian S, Grobe JL, Yuan L, Narielwala DR, Walter GA, Katovich MJ, Raizada MK. Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology. Hypertension 2008; 51:712-718.